Marshall Islands vs Syrian Arab Republic: Immunization, Hib3
Marshall Islands
72.0%
in 2024
Syrian Arab Republic
73.0%
in 2024
Marshall Islands rank
160th
Syrian Arab Republic rank
157th
Immunization, Hib3 over time
- Marshall Islands
- Syrian Arab Republic
How they compare
Syrian Arab Republic currently reports 73.0% against 72.0% in Marshall Islands, a difference of 1.0%.
The two have swapped places 2 times across 24 shared years of data; in 2001 it was Syrian Arab Republic ahead.
Marshall Islands ranks 160th and Syrian Arab Republic ranks 157th of 191 countries.
Across the 3 decades both report, Marshall Islands averaged higher in 2 and Syrian Arab Republic in 1.
Head to head by decade
| Decade | Marshall Islands | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.6% | 81.0% | 9.4% | Syrian Arab Republic |
| 2010s | 70.7% | 61.7% | 9.0% | Marshall Islands |
| 2020s | 71.8% | 64.2% | 7.6% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Marshall Islands or Syrian Arab Republic?
- Syrian Arab Republic, at 73.0% against 72.0% in Marshall Islands as of 2024.
- What is the difference in immunization, hib3 between Marshall Islands and Syrian Arab Republic?
- 1.0%, with Syrian Arab Republic ahead.
- How many years of comparable data are there for Marshall Islands and Syrian Arab Republic?
- 24 years are reported by both, from 2001 to 2024.
- How do Marshall Islands and Syrian Arab Republic rank globally for immunization, hib3?
- Marshall Islands ranks 160th and Syrian Arab Republic ranks 157th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.